Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.
CoreMap, a US-based developer of a cure for atrial fibrillation spun out of University of Vermont, has concurrently completed a $3m series A extension and $20m series B round from undisclosed strategic, institutional, venture and individual investors. CoreMap previously raised an initial $10.5m in series A financing led by Qure Ventures, with participation from The Fund at Hula, in September 2020.
Odaia, a Canada-based commercial insights platform aimed at pharmaceutical firms based on University of Toronto research, has obtained $13.8m in a series A round led by Flint Capital, TechCrunch reported yesterday. Innospark Ventures, Alumni Ventures, Graphite Ventures, BDC Capital, MaRS IAF, StandUp Ventures, Panache Ventures and unnamed existing backers took part in the round. The cash will allow Odaia to build out platform features and to hire additional sales, marketing and customer support staff as it eyes an expansion. Odaia previously pocketed $1.6m in a seed round in…
Thierry Heles
Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
